Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Buzz on the Bullboards: Energy, cannabis, and biotech shine on the TSX

Canada’s main stock index experienced significant movement this week, largely influenced by global trade developments and policy decisions. On Monday, the TSX surged in alignment with a global rally after U.S. President Donald Trump eased some of his tarif...

Insider buying: Almonty Industries CEO buys again

Two purchases in just a few days – what is behind Lewis Black’s confidence in his own company, and why could tungsten soon become the most strategically important metal in the Western world? In times of geopolitical tension, it is often the small signals t...

Tungsten: Building the next-generation of defense systems

Now, most of the world has now heard about this company, Almonty Industries . This is a leading tungsten producer with projects in Portugal and Spain, and soon to be launching production at its flagship, Sangdong Tungsten Mine in South Korea. The company recently r...

Buzz on the Bullboards: TSX stocks making headlines in a U.S. trade war

This week, Canada’s main stock index, the TSX , experienced significant volatility, plunging over 300 points at the start of the trading week on Monday. Traders are avoiding risks due to ongoing concerns about the global trade war. Former central banker M...

Decoding patient data sets to help clinical trials succeed

How well do you know your clinical patients? What if there was a way to uncover the hidden relationship between patients in clinical trials empowering scientists to make critical decisions. Lyndsay Malchuk from Stockhouse Publishing recently sat down with NetraMark Hold...

Buzz on the Bullboards: Despite tariffs, Bombardier flying high

Canada’s main stock index has been moving lower this week, as investors stepped away from big bets, driven by declines in energy, tech, and industrial companies. The index had already felt the weight of new potential U.S. tariffs on steel and aluminum...

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

The company revolutionizing access to care and natural remedies

The Market Online recently spoke with Liz Viccars, CEO of AJA Health and Wellness Inc. (TSXV:AJA) a company transforming healthcare with its total health access service offering telemedicine, diagnostics and specialized care via proprietary tech. Additionally, AJA Heal...
1 2 3 4 5 6 7 8 9 10 ...